Drug targets in prostate cancer: an appetite for KLK2-mediated destruction. Blinka S, Yu EY. Clin Cancer Res 2025 Sep 9. doi: 10.1158/1078-0432.CCR-25-2546.

Read + Share

Amedeo Smart

Independent Medical Education

Blinka S, Yu EY. Drug targets in prostate cancer: an appetite for KLK2-mediated destruction. Clin Cancer Res 2025 Sep 9. doi: 10.1158/1078-0432.CCR-25-2546.
PMID: 40924642